Back

Perfusion balloon prolonged inflation in lipid-rich coronary lesions and slow flow/no-reflow: NIRS-IVUS insights

31 August 2026 (10:15 - 11:00)
Organised by: Logo
Congress Presentation Part of: Optimising outcomes in percutaneous coronary intervention: risk assessment, pharmacotherapy, and clinical insights Percutaneous Coronary Intervention (PCI) ESC Professional Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Shintaro Izumoto

University of Miyazaki, Miyazaki (Japan)

3 More presentations in this session

Presentation thumbnail
CKD severity and high bleeding risk in patients undergoing PCI: stage-specific validation of modified ARC-HBR criteria
Doctor F. Di Muro (Salerno, IT)
Abstract Slides Video
Presentation thumbnail
Association of ANGPTL3, ANGPTL4, and DOCK7 polymorphisms with lipid traits and long-term clinical outcomes in patients undergoing PCI
Doctor Y. Song (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
Early bleeding risk prediction with the PRECISE-HBR score in PCI patients treated with cangrelor: the ICARUS registry
Doctor V. De Sio (Caserta, IT)
Abstract Slides Video

Access the full session

Session thumbnail
Optimising outcomes in percutaneous coronary intervention: risk assessment, pharmacotherapy, and clinical insights

The Event

Event poster

ESC Congress 2026

31 August 2026 10:15 CET
You may be interested in
thumbnail
Congress Presentation
Impact of NIRS-IVUS-identified lipid-rich plaques on microvascular resistance reserve after PCI
28 August 2026
thumbnail
Congress Presentation
Clinical impact of drug-coated balloon inflation time: a nationwide analysis from SCAAR
31 August 2025
thumbnail
Congress Presentation
Efficacy and safety of long-time pre-dilation with perfusion balloon prior to stent implantation in acute myocardial infarction
31 August 2026
thumbnail
Congress Presentation
Progressive lesion-level hemodynamic improvement from immediate post-procedural assessment to follow-up after balloon pulmonary angioplasty
31 August 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources